Cargando…

Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study

BACKGROUND: Clinical trials show high efficacy of sofosbuvir/velpatasvir (SOF/VEL), but there are limited data from “real-world” settings. We aimed to evaluate SOF/VEL effectiveness for all hepatitis C virus (HCV) genotypes (GTs) in British Columbia (BC), Canada. METHODS: We used the BC Hepatitis Te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilton, James, Wong, Stanley, Yu, Amanda, Ramji, Alnoor, Cook, Darrel, Butt, Zahid A, Alvarez, Maria, Binka, Mawuena, Darvishian, Maryam, Jeong, Dahn, Bartlett, Sofia R, Pearce, Margo E, Adu, Prince A, Yoshida, Eric M, Krajden, Mel, Janjua, Naveed Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052750/ https://www.ncbi.nlm.nih.gov/pubmed/32154326 http://dx.doi.org/10.1093/ofid/ofaa055

Ejemplares similares

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
por: Samji, Hasina, et al.
Publicado: (2020)

Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia
por: Jeong, Dahn, et al.
Publicado: (2021)

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019
por: Pearce, Margo E., et al.
Publicado: (2020)

Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study
por: Makuza, Jean Damascene, et al.
Publicado: (2022)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort
por: Darvishian, Maryam, et al.
Publicado: (2022)

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
por: Binka, Mawuena, et al.
Publicado: (2018)

Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study
por: Pearce, Margo E., et al.
Publicado: (2021)

Cohort profile: the British Columbia COVID-19 Population Mixing Patterns Survey (BC-Mix)
por: Adu, Prince A, et al.
Publicado: (2022)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes
por: Butt, Zahid A, et al.
Publicado: (2020)

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
por: Heo, Jeong, et al.
Publicado: (2023)

Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada
por: Darvishian, Maryam, et al.
Publicado: (2021)

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
por: Childs-Kean, Lindsey M, et al.
Publicado: (2019)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis
por: Ren, Xiao-Dan, et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
por: Ruane, Peter, et al.
Publicado: (2019)

Contact patterns during the COVID-19 pandemic: findings from British Columbia, Canada
por: Adu, P., et al.
Publicado: (2022)

The Impact of Mask Mandates on Face Mask Use During the COVID-19 Pandemic: Longitudinal Survey Study
por: Binka, Mawuena, et al.
Publicado: (2023)

Quantifying Contact Patterns: Development and Characteristics of the British Columbia COVID-19 Population Mixing Patterns Survey
por: Adu, P., et al.
Publicado: (2022)

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
por: Mangia, Alessandra, et al.
Publicado: (2020)

Social Contacts and Transmission of COVID-19 in British Columbia, Canada
por: Ringa, Notice, et al.
Publicado: (2022)

Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada
por: Velásquez García, Héctor A., et al.
Publicado: (2023)

Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients – short report
por: Piekarska, Anna, et al.
Publicado: (2020)

A large linked data platform to inform the COVID-19 response in British Columbia: The BC COVID-19 Cohort.
por: Wilton, James, et al.
Publicado: (2022)

Impact of COVID‐19 pandemic on HCV care cascade in Rwanda: Ecological study from July 2019 to June 2021
por: Makuza, Jean Damascene, et al.
Publicado: (2022)

Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection
por: Ahmed, Rowan, et al.
Publicado: (2021)

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir
por: Abi-Saleh, Simon P, et al.
Publicado: (2023)

Towards targeted screening for acute HIV infections in British Columbia
por: Steinberg, Malcolm, et al.
Publicado: (2011)

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019)

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
por: Mir, Fazia, et al.
Publicado: (2017)

Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
por: Murayama, Aiko, et al.
Publicado: (2021)

Selective and sensitive spectrofluorimetric quantification of velpatasvir in presence of sofosbuvir. Application to their co-formulated tablet
por: El-Gamal, Rania M., et al.
Publicado: (2018)

Estimating the net value of treating hepatitis C virus using sofosbuvir-velpatasvir in India
por: Bloom, David E., et al.
Publicado: (2021)

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders
por: Wedemeyer, Heiner, et al.
Publicado: (2022)

Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study
por: Setayeshgar, Solmaz, et al.
Publicado: (2023)

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants
por: Janjua, Naveed Zafar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g45ai17gndu9sp4mgnclgndu0g